AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novel Coronavirus Treatment

983.278

+8.2420.85%

Number of Gainers:7

Number of Losers:7

Number of Flat:19

PE:- -

High:984.647

Open:973.802

Low:973.706

Close:975.036

Volume:21.95M

Turnover:294.85M

Market Cap:243.02B

Float Cap:199.46B

Loading ...

ASX Preview: Australian Shares to Rise as Oil Climbs on Saudi Attacks; CSL Partners With Alentis Therapeutics to Develop Rare Kidney, Liver Disease Drug

MT Newswires Live

Fisher & Paykel Healthcare Sells South Auckland Land to Health New Zealand for Over NZ$45 Million

MT Newswires Live

CSL Enters Global Lixudebart Partnership with Alentis, Pays Us$355 Million Upfront

CSL and Alentis Announce Global Partnership to Develop and Commercialise Lixudebart for Rare Kidney and Liver Diseases

THOMSON REUTERS

Australia's CSL Strikes Kidney, Liver Disease Drug Deal Worth up to $1.6 Billion

To Pay Alentis $355 Mln Upfront and up to $1.2 Bln in Milestones

THOMSON REUTERS

To Fully Fund Phase 2 and Phase 3 Trials for Lixudebart

THOMSON REUTERS

CSL Limited-CSL Enters Exclusive Agreement with Alentis Therapeutics

THOMSON REUTERS

Enters Agreement with Alentis to Co-Develop and Co-Promote Lixudebart

THOMSON REUTERS

3 ASX Stocks That Might Be Trading Below Fair Value Estimates

Simply Wall St.

US FDA Advisers Recommend Flu Vaccine Strains for 2027 Southern Hemisphere Season

Australia Household Spending Shows Some Positive Signals

Coles Group's Proposed Supermarket Lease in South Australia Faces ACCC Review

MT Newswires Live

Starpharma Holdings Appoints Russell Basser as Chair

Starpharma - Rob Thomas Ao to Retire as Chair at Conclusion of 2026 AGM

THOMSON REUTERS

Starpharma Holdings Ltd-Chair and Deputy Chair Appointments

THOMSON REUTERS

ASX Growth Companies With High Insider Ownership September 2026

Simply Wall St.

CSL Still Generates Caution Despite Rerate

ASX Midday Sector Update: Real Estate Stocks Advance, Consumer Staples Sector Struggles

MT Newswires Live

Ansell Opens Innovation Studio in Portugal

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/BK7501/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":983.2778,"timestamp":1791349200017,"preClose":975.0362,"halted":0,"volume":21945425,"delay":0,"changeRate":0.008453,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":8.241577,"latestTime":"10-07 16:00:00 AEDT","open":973.8016,"high":984.6473,"low":973.7056,"amount":294852877,"amplitude":0.011222,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791414000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791327600000,1791349200000]],"turnoverRate":0.001533,"increases":7,"decrements":8,"flats":17,"marketCap":243022701378.25,"floatMarketCap":199462250987.5547},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":984.6473,"amplitude":0.011222,"preClose":975.0362,"low":973.7056,"latestPrice":983.2778,"volume":21945425,"delay":0,"open":973.8016,"prevYearClose":900.1661,"prevWeekClose":966.403,"prevMonthClose":999.613,"prevQuarterClose":999.613,"fiveDayClose":999.613,"twentyDayClose":959.274,"sixtyDayClose":823.643,"secType":"PLATE","market":"AU","turnoverRate":0.001533,"marketCap":243022701378.25,"floatMarketCap":199462250987.5547,"timestamp":1791349200017,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":7,"down":7,"flat":19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673776492","title":"ASX Preview: Australian Shares to Rise as Oil Climbs on Saudi Attacks; CSL Partners With Alentis Therapeutics to Develop Rare Kidney, Liver Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776492","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776492?lang=en_us&edition=fundamental","pubTime":"2026-10-05 07:07","pubTimestamp":1791155252,"startTime":"0","endTime":"0","summary":"Australian shares are poised to rise on Monday after oil prices climbed as attacks claimed by Yemen's Iran-backed Houthis on Saudi Aramco sites raised concerns about potential disruptions to crude production.Oil prices were also supported after the Organization of the Petroleum Exporting Countries decided to keep its November output targets unchanged, limiting expectations for additional supply and helping keep Brent crude above $100 a barrel amid the Iran war.On Oct. 2, the S&P 500, the Nasdaq Composite, and the Dow Jones Industrial Average rose 0.7%, 1.2%, and 0.5%, respectively.In the macroeconomy, Australia's private-sector growth slowed in September as weaker new business weighed on services activity, prompting a resumption of job cuts while inflationary pressures intensified, according to a monthly survey by S&P Global released Monday.In corporate news, CSL  entered a partnership with Alentis Therapeutics to co-develop and co-promote lixudebart, a potential first-in-class therapy","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IIGF.AU","QRE.AU","STW.AU","IMLC.AU","BEAR.AU","BBOZ.AU","BK4139","OZR.AU","E200.AU","VAS.AU","EIGA.AU","BK7067","BK7508","BK4007","OZF.AU","BK4539","CMM.AU","GEAR.AU","GIVE.AU","ZYAU.AU","LENZ","QFN.AU","XKO.AU","IOZ.AU","BK7511","BK7501","CSL.AU","VAP.AU","BK7104","SLF.AU","XJO.AU","IISV.AU","XAO.AU","DACE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673765587","title":"Fisher & Paykel Healthcare Sells South Auckland Land to Health New Zealand for Over NZ$45 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2673765587","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673765587?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:16","pubTimestamp":1791152175,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare  agreed to sell 13 hectares of its Karaka Road site in Drury to Health New Zealand for NZ$45.3 million, paving the way for a future hospital to serve South Auckland, according to a Monday filing with the New Zealand and Australian bourses.The site will form part of the company's planned second New Zealand campus, with the remaining land retained for future development, per the filing.Settlement is expected to occur between March and June 2027, subject to certain conditions, while the rezoning application for the wider site remains under review by Auckland Council, the filing said.The transaction will be recognized as an exceptional item, with its financial impact excluded from the previously issued fiscal 2027 earnings guidance, the filing added.The company expects fiscal 2027 net profit after tax of around NZ$525 million to NZ$565 million and operating revenue of about NZ$2.47 billion to NZ$2.57 billion, an earlier filing showed.The company's New Zealand sha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","NZ20C.NZ","T10G.NZ","BK4581","BK4588","FPH.AU","XLV","FPH.NZ","FNZ.NZ","NZT.NZ","BK8004","XBI","BK7007","BK4585","NZG.NZ","TNZ.NZ","LABU","NZ50G.NZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673768577","title":"CSL Enters Global Lixudebart Partnership with Alentis, Pays Us$355 Million Upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2673768577","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673768577?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:42","pubTimestamp":1791150175,"startTime":"0","endTime":"0","summary":"CSL enters global lixudebart partnership with Alentis, pays US$355 million upfrontCSL entered an exclusive global collaboration with Alentis Therapeutics to co-develop, co-promote lixudebart for rare ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261004:nNDL9fTHVp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","BK7067","CSL.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776854","title":"CSL and Alentis Announce Global Partnership to Develop and Commercialise Lixudebart for Rare Kidney and Liver Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776854","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776854?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:42","pubTimestamp":1791150151,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261004:nTUABRZMKD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7511","BK7067","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673750477","title":"Australia's CSL Strikes Kidney, Liver Disease Drug Deal Worth up to $1.6 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2673750477","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673750477?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:37","pubTimestamp":1791149849,"startTime":"0","endTime":"0","summary":"Australia's CSL strikes kidney, liver disease drug deal worth up to $1.6 billionOct 5 -Australia's CSLCSL.AXsaid on Monday it had entered into an agreement with Switzerland-based Alentis Therapeutics to co-develop and co-promote a treatment for rare kidney and liver diseases, in a deal worth up to $1.6 billion before development funding.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261004:nL1N45Q05Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","CSL.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673775745","title":"To Pay Alentis $355 Mln Upfront and up to $1.2 Bln in Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2673775745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673775745?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:22","pubTimestamp":1791148963,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261004:nTUE73SZKR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","CSL.AU","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673775723","title":"To Fully Fund Phase 2 and Phase 3 Trials for Lixudebart","url":"https://stock-news.laohu8.com/highlight/detail?id=2673775723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673775723?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:22","pubTimestamp":1791148963,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261004:nTUE73SZKR:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","CSL.AU","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673775717","title":"CSL Limited-CSL Enters Exclusive Agreement with Alentis Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2673775717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673775717?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:22","pubTimestamp":1791148963,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261004:nTUE73SZKR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","CSL.AU","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673775710","title":"Enters Agreement with Alentis to Co-Develop and Co-Promote Lixudebart","url":"https://stock-news.laohu8.com/highlight/detail?id=2673775710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673775710?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:22","pubTimestamp":1791148963,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261004:nTUE73SZKR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7511","BK7067","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673775120","title":"3 ASX Stocks That Might Be Trading Below Fair Value Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2673775120","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673775120?lang=en_us&edition=fundamental","pubTime":"2026-10-05 03:04","pubTimestamp":1791140659,"startTime":"0","endTime":"0","summary":"The Australian stock market has experienced significant volatility recently, with a sharp decline on Thursday followed by a potential positive opening influenced by Wall Street's performance and optimism in Asian markets. In this fluctuating environment, identifying stocks that might be trading below their fair value estimates can offer investors opportunities to potentially capitalize on market inefficiencies.","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6022000-choice2-card/1788952027985","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6022000-choice2-card/1788952027985"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-ann/ansell-shares/news/3-asx-stocks-that-might-be-trading-below-fair-value-estimate","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ann/ansell-shares/news/3-asx-stocks-that-might-be-trading-below-fair-value-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NOL.AU","ANN.AU","GGP.AU","BK7143","QAL.AU","BK7121","LBL.AU","BK7088","BK7104","BK7506","WDS.AU","BK7501","MTO.AU","BK7142","BK4585","SPHQ","SGLLV.AU","BK7126","BK4588","BK7141","BK7062","BK7089","WGX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672766765","title":"US FDA Advisers Recommend Flu Vaccine Strains for 2027 Southern Hemisphere Season","url":"https://stock-news.laohu8.com/highlight/detail?id=2672766765","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672766765?lang=en_us&edition=fundamental","pubTime":"2026-10-02 01:01","pubTimestamp":1790874064,"startTime":"0","endTime":"0","summary":"US FDA advisers recommend flu vaccine strains for 2027 Southern Hemisphere seasonOct 1 (Reuters)-A panel of advisers to the US FDA on Thursday recommended the virus strains vaccine manufacturers shoul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL4N45M0VF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7511","BK7067","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672739697","title":"Australia Household Spending Shows Some Positive Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672739697","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672739697?lang=en_us&edition=fundamental","pubTime":"2026-10-01 11:08","pubTimestamp":1790824080,"startTime":"0","endTime":"0","summary":"0308 GMT - Australia's August household spending data includes positive signals for shares of companies, including car dealer Eagers Automotive, Morgans analysts say. They point out that transport was the strongest spending category for the month. While this includes fuel, they tell clients in a note that sales of new vehicles also contributed, supported by demand for electric vehicles. Elsewhere, they see consumers still willing to spend on food, hotels, cafes and restaurants. They see this as positive for fast-food store operators Collins Foods and Guzman Y Gomez and supermarket operators Woolworths and Coles.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APE.AU","CKF.AU","BK7143","GYG.AU","BK7501","BK7040","BK7137","WOW.AU","BK7082","COL.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672736115","title":"Coles Group's Proposed Supermarket Lease in South Australia Faces ACCC Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2672736115","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672736115?lang=en_us&edition=fundamental","pubTime":"2026-10-01 10:15","pubTimestamp":1790820948,"startTime":"0","endTime":"0","summary":"Coles Group's  proposed lease of a supermarket in Angle Vale, South Australia, is under a phase one initial review by the Australian Competition and Consumer Commission , the regulator said Wednesday.Coles has signed a letter of offer with Australian private firm Merenda Group for the lease, with the proposed Coles supermarket expected to open around November 2029.The ACCC is seeking feedback on the proposal through a consultation that runs until Oct. 7.Coles Group shares fell 2% in recent Thursday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GIVE.AU","IMLC.AU","ZYAU.AU","BBOZ.AU","COL.AU","XJO.AU","IISV.AU","E200.AU","XKO.AU","OZR.AU","QRE.AU","VAP.AU","VAS.AU","STW.AU","BK7082","QFN.AU","BK7501","DACE.AU","EIGA.AU","GEAR.AU","IIGF.AU","SLF.AU","BEAR.AU","IOZ.AU","BK7040","XAO.AU","OZF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672073681","title":"Starpharma Holdings Appoints Russell Basser as Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2672073681","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672073681?lang=en_us&edition=fundamental","pubTime":"2026-10-01 09:51","pubTimestamp":1790819484,"startTime":"0","endTime":"0","summary":"BRIEF-Starpharma Holdings Appoints Russell Basser As ChairOct 1 (Reuters)-Starpharma Holdings LtdSPL.AX:CHAIR AND DEPUTY CHAIR APPOINTMENTSAPPOINTS RUSSELL BASSER AS CHAIR AND DAVID MCINTYRE AS DEPUTY","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUE5DHXTY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","SPL.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672832735","title":"Starpharma - Rob Thomas Ao to Retire as Chair at Conclusion of 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2672832735","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672832735?lang=en_us&edition=fundamental","pubTime":"2026-10-01 08:44","pubTimestamp":1790815481,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUE5DHXTY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPL.AU","BK7508","BK7501","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672673588","title":"Starpharma Holdings Ltd-Chair and Deputy Chair Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2672673588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672673588?lang=en_us&edition=fundamental","pubTime":"2026-10-01 08:44","pubTimestamp":1790815481,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUE5DHXTY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPL.AU","BK7096","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672411738","title":"ASX Growth Companies With High Insider Ownership September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672411738","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672411738?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:08","pubTimestamp":1790795293,"startTime":"0","endTime":"0","summary":"In the wake of the recent RBA rate increase, the Australian market is experiencing a period of volatility, with mixed signals from global markets and fluctuating commodity prices adding to investor uncertainty. Amidst these conditions, growth companies with high insider ownership can offer unique insights into potential resilience and alignment between management and shareholder interests, making them noteworthy in today's economic climate.","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-growth-companies-with-high-insider-ownership-september-2-5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-growth-companies-with-high-insider-ownership-september-2-5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GEAR.AU","BK4108","ZYAU.AU","EMR.AU","BK7137","BK7084","FRS.AU","IIGF.AU","BK4526","BK4552","OZF.AU","PDI.AU","QRE.AU","VAS.AU","XJO.AU","IMLC.AU","BK7104","GIVE.AU","BK7508","AEM.AU","BK7501","STW.AU","BK7095","AR1.AU","BK4531","DACE.AU","AV1.AU","IQ","SPL.AU","OZR.AU","XAO.AU","XKO.AU","EIQ.AU","VAP.AU","BK7017","EIGA.AU","SLF.AU","BEAR.AU","ELS.AU","E200.AU","GYG.AU","IOZ.AU","MSB.AU","BBOZ.AU","SKS.AU","WZR.AU","BK7023","BK7093","QFN.AU","IISV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671227775","title":"CSL Still Generates Caution Despite Rerate","url":"https://stock-news.laohu8.com/highlight/detail?id=2671227775","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671227775?lang=en_us&edition=fundamental","pubTime":"2026-09-30 12:52","pubTimestamp":1790743920,"startTime":"0","endTime":"0","summary":"0452 GMT - CSL still generates caution at Macquarie despite the stock's recent rerate. Analysts at the investment bank keep a neutral rating on the Australia-based pharmaceutical company, observing that a 58% share-price rise over three months came despite earnings downgrades. They think that near-term catalysts will probably support the current rerating, but tell clients in a note that they are cautious on the medium-term outlook due to uncertainty over the impact on demand of complement-inhibitor therapies, albumin collections, and the process to appoint a new permanent CEO. Macquarie raises its target price on the stock 31% to 174.00 Australian dollars. Shares are up 1.4% at A$184.25.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7511","CSL.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671224732","title":"ASX Midday Sector Update: Real Estate Stocks Advance, Consumer Staples Sector Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2671224732","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671224732?lang=en_us&edition=fundamental","pubTime":"2026-09-30 11:13","pubTimestamp":1790737990,"startTime":"0","endTime":"0","summary":"Real estate stocks advanced 3%, leading a broad-based rally at midday Wednesday.Goodman Group  gained nearly 3% in recent trade.Meanwhile, the consumer staples sector struggled, the only sector in the red, recording a marginal decline.Woolworths Group  shares were down almost 1% in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7040","BK7099","BK7511","BK7510","GMG.AU","WOW.AU","BK7501","BK7155"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671226373","title":"Ansell Opens Innovation Studio in Portugal","url":"https://stock-news.laohu8.com/highlight/detail?id=2671226373","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671226373?lang=en_us&edition=fundamental","pubTime":"2026-09-30 08:48","pubTimestamp":1790729287,"startTime":"0","endTime":"0","summary":"Ansell  opened an Ansell Xperience & Innovation Studio in Portugal to service the European market, according to a Tuesday statement.The launch marks the second such studio following the opening of the first center in Georgia, US, in October 2025.Ansell describes the studios as \"an immersive, collaborative environment for solving tomorrow's safety challenges through education, experimentation, and co-creation.\"","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANN.AU","BK7501","BK7126"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":79,"code":"91000000","status":"200"}]}}